The phase 3 PhALLCON trial showed a trend toward improved EFS in patients with Ph+ newly diagnosed ALL when treated with ponatinib compared with imatinib.
Addressing moral distress means not just obtaining ethics consultation as needed but also dealing with the feeling of powerlessness that often accompanies it.
Researchers sought to determine whether there were delays in or discontinuation of treatment for cancer among different populations during the COVID-19 pandemic.
AANP and AAPA Presidents discuss how elimination of the X-Waiver and patient caps for buprenorphine prescription for opioid use disorder will affect clinical practice.
AML research presented at ASH 2022 highlighted promising combination regimens and suggested that some patients may benefit from less intensive treatment.
Climate change has already damaged human health, food supplies, and the environment. Rapid, decisive, coordinated action is needed to avert catastrophic health impacts.
The number of US health care providers certified to prescribe buprenorphine more than doubled in the past 4 years, and treatment advocates hope to see that trend continue.
Research in patients with CLL showed that zanubrutinib can outperform ibrutinib, a triplet is effective for high-risk CLL, cell death may predict the depth of response, and a CAR T-cell therapy is likely not an option for CLL patients.
This review describes specialized programs for adolescent and young adults with cancer and the process undertaken by a US facility to develop its program.
HIPAA protects patients from unauthorized disclosure of personal information by covered entities such as medical practices and hospitals, but out from under the HIPAA umbrella, patients are mostly on their own, according to the authors of a recent report.
This review article discusses how cancer care may cause survivors of sexual trauma to re-experience their trauma and offers tips on how to mitigate this potential.
The SAFER program is helping Ukrainian children with cancers and other blood disorders to continue their therapy in Ukraine at centers in Europe and North America.
New topics in the ACCP guideline include the perioperative management of patients receiving direct oral anticoagulants and P2Y12 inhibitor antiplatelet drugs.
In addition to the physical risks, experts anticipate a myriad of mental health ramifications stemming from the loss of abortion access and the associated economic and occupational repercussions.
Researchers sought to determine the effectiveness of using electronic health record prompts to assess patients for smoking, desire to quit, and access to smoking cessation programs.
Dr Jeffery J. Auletta, from NMDP/Be The Match, reviews data on mismatched unrelated donor transplants in a diverse population of patients with hematologic malignancies.
